SYMBIOTEC PHARMALAB LTD share price
NSE: SYMBIOTEC · ISIN INE899I01028
Key numbers
- Market cap
- -
- Current price
- ₹ 1,003.35
- 52-week high / low
- ₹ 1,194 / 934
- Stock P/E
- 58.7
- Book value
- ₹ 183.3
- Dividend yield
- 0.00%
- ROCE
- 12.3%
- ROE
- 11.2%
- Debt to equity
- 0.34
- Sales growth (3 yrs)
- 16.8%
- Profit growth (3 yrs)
- 67.3%
- 1-year return
- -
About SYMBIOTEC PHARMALAB LTD
Symbiotec Pharma Lab Pvt. Ltd. develops, manufactures, and markets active pharmaceutical ingredients (APIs), with a primary focus on cortico-steroids and steroid-hormone APIs in both sterile and non-sterile forms. The company synthesizes progestin, estrone, testosterone, their derivatives, and anabolic steroids, supplying these in commercial volumes globally. It offers APIs and intermediate pharmaceutical products for therapeutic areas such as gastrointestinal ailments, cardiovascular disease, pain management, paediatrics, anti-infective, and dermatology. The company provides contract manufacturing (CMO) and contract development and manufacturing (CDMO) services, particularly for fermentation-based APIs, and operates large-scale manufacturing facilities with dedicated research and development and quality control laboratories. Its product portfolio includes APIs outside the cortico-steroids and hormone categories, with several products under development. The company serves clients in the pharmaceutical industry, including organizations involved in pharmaceutical manufacturing, contract manufacturing, and research and development, as well as global pharmaceutical companies. The…
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | |
|---|---|
| Sales | 200 |
| Operating profit | 58 |
| Net profit | 30 |
| EPS (₹) | 4.66 |
Peers in Drug Manufacturers - General
Data for information only, not investment advice. Prices end of day.